Braidwell LP Keros Therapeutics, Inc. Call Options Transaction History
Braidwell LP
- $1.63 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KROS
# of Institutions
155Shares Held
38.6MCall Options Held
834KPut Options Held
969K-
Adar1 Capital Management, LLC Austin, TX5.39MShares$73.9 Million11.03% of portfolio
-
Madison Avenue Partners, LP New York, NY2.69MShares$36.9 Million3.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.63MShares$36.1 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$35.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$34.5 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $353M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...